Simvastatin induces adverse effects on proliferation and mineralization of human primary osteoblasts

被引:0
作者
Martin Mariano Isabelo Sabandal
Edgar Schäfer
Jonathan Aed
Susanne Jung
Johannes Kleinheinz
Sonja Sielker
机构
[1] University of Münster,Central Interdisciplinary Ambulance in the School of Dentistry
[2] University Hospital Münster,Department of Cranio
来源
Head & Face Medicine | / 16卷
关键词
Mineralization; Osteoblasts; Adverse effects; Simvastatin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 198 条
[1]  
Siddiqui JA(2016)Physiological bone remodeling: systemic regulation and growth factor involvement Physiology (Bethesda) 31 233-245
[2]  
Partridge NC(2006)Bone remodeling Ann N Y Acad Sci 1092 385-396
[3]  
Hadjidakis DJ(2015)Potential mechanisms and applications of statins on osteogenesis: current modalities, conflicts and future directions J Control Release 215 12-24
[4]  
Androulakis II(2013)Cancer-associated bone disease Osteoporos Int 24 2929-2953
[5]  
Oryan A(2011)Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports Head Face Med 7 7-460
[6]  
Kamali A(2007)The effects of medications on bone J Am Acad Orthop Surg 15 450-1263
[7]  
Moshiri A(2012)Short time administration of antirheumatic drugs - methotrexate as a strong inhibitor of osteoblast's proliferation in vitro Head Face Med 8 26-11
[8]  
Rizzoli R(1994)Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor gene Arterioscler Thromb 14 1258-498
[9]  
Body JJ(2014)The pharmacology of statins Pharmacol Res 88 3-114
[10]  
Brandi ML(2015)The past, present and future of lipidlowering therapy Clin Lipidol 10 481-5335